www.nature.com/articles/s41...
GRIN2A null variants confer high risk early-onset schizophrenia mental disorders & potentially enable precision therapy
@atanas-g-atanasov.bsky.social
@mariaoconnor.bsky.social
@nonlinearbotanist.bsky.social
@mfamyfuerza.bsky.social
www.nature.com/articles/s41...
GRIN2A null variants confer high risk early-onset schizophrenia mental disorders & potentially enable precision therapy
@atanas-g-atanasov.bsky.social
@mariaoconnor.bsky.social
@nonlinearbotanist.bsky.social
@mfamyfuerza.bsky.social
medicalxpress.com/news/2025-11...
— 121 ppl with GRIN2A variant analyzed
— GRIN2A variants reduce activity of NMDA receptor
— 4 patients benefit with dietary supplement L-serine
#health #science 🧪
medicalxpress.com/news/2025-11...
— 121 ppl with GRIN2A variant analyzed
— GRIN2A variants reduce activity of NMDA receptor
— 4 patients benefit with dietary supplement L-serine
#health #science 🧪
https://go.nature.com/4hhFRRm
https://go.nature.com/4hhFRRm
Susanne, @sibing.bsky.social, successfully defended her doctoral dissertation @hpi.bsky.social this month on “Computational Strategies for Chronic Disease Characterization and Treatment by Leveraging Electronic Health Records and Omics Data” 🩻🧬👩🏼💻
Susanne, @sibing.bsky.social, successfully defended her doctoral dissertation @hpi.bsky.social this month on “Computational Strategies for Chronic Disease Characterization and Treatment by Leveraging Electronic Health Records and Omics Data” 🩻🧬👩🏼💻